UPLOAD Filing
PRECIGEN, INC.
Date: Aug. 26, 2025 · CIK: 0001356090 · Accession: 0000000000-25-009106
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289719
Letter
Re: Precigen, Inc. Registration Statement on Form S-3 Filed August 19, 2025 File No. 333-289719 Dear Helen Sabzevari:
August 26, 2025
Helen Sabzevari President and Chief Executive Officer Precigen, Inc. 20374 Seneca Meadows Parkway Germantown, MD 20876
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Arisa A. Sin
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 26, 2025 Helen Sabzevari President and Chief Executive Officer Precigen, Inc. 20374 Seneca Meadows Parkway Germantown, MD 20876 Re: Precigen, Inc. Registration Statement on Form S-3 Filed August 19, 2025 File No. 333-289719 Dear Helen Sabzevari: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Arisa A. Sin </TEXT> </DOCUMENT>